Vimarsana
Biggest News Aggregation in the World

Page 19 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

SSc Autoantibody Identified with Link to GI Dysfunction - Vimarsana News

SSc Autoantibody Identified with Link to GI Dysfunction

If validated as a biomarker, anti-gephyrin autoantibodies could help identify patients at higher risk for GI symptoms like constipation.

Low-Dose Steroids May Not Increase CV Risk in RA - Vimarsana News

Low-Dose Steroids May Not Increase CV Risk in RA

A daily prednisolone dose of less than 5 mg was not associated with increased cardiovascular risk, whereas a dose of 5 mg or more doubled the risk for major adverse cardiovascular events.

Amgen Quarterly Revenue Rises 6%, Profit Beats Street Estimates - Vimarsana News

Amgen Quarterly Revenue Rises 6%, Profit Beats Street Estimates

The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects a deal to acquire Horizon Therapeutics to close by mid-December.

Autoantibodies Could Help Predict Cancer Risk in Scleroderma - Vimarsana News

Autoantibodies Could Help Predict Cancer Risk in Scleroderma

The autoantibodies anti-POLR3 and monospecific anti-Ro52 were associated with increased cancer risk, while anti-centromere and anti-U1RNP were tied to reduced risk.

Tools May Predict Inflammatory Arthritis in At-Risk Patients - Vimarsana News

Tools May Predict Inflammatory Arthritis in At-Risk Patients

The two tool scores could help determine who can be managed in primary care and who may qualify for intervention studies.